Scientists have discovered five biological variants of Alzheimer's disease, which may require different treatment. As a result, previously tested drugs may incorrectly appear to be ineffective or only minimally effective. The research results will be published in Nature Aging.
In those with Alzheimer's disease, the amyloid and tau protein clump in the brain. In addition to these clumps, other biological processes such as inflammation and nerve cells growth are also involved. Using new techniques, the researchers have been able to measure these other processes in the cerebrospinal fluid of patients with amyloid and tau clumps.
The researchers examined 1058 proteins in the cerebrospinal fluid of 419 people with Alzheimer's disease. They found that there are five biological variants within this group.
The first variant is characterized by increased amyloid production. In a second type, the blood-brain barrier is disrupted and there is a reduced amyloid production and less nerve cells growth.
Furthermore, the variants differ in the degree of protein synthesis, the functioning of the immune system, and the functioning of the organ that produces cerebrospinal fluid. Patients with different Alzheimer's variants also showed differences in other aspects of the disease. For example, the researchers found a faster course of the disease in certain subgroups.
The findings are of great importance for drug research. It means that a drug could only work in one variant of Alzheimer's disease. For example, medication that inhibits amyloid production may work in the variant with increased amyloid production but may be harmful in the variant with decreased amyloid production. It is also possible that patients with one variant have a higher risk of side effects, while that risk is much lower with other variants.
The next step for the research team is to show that the Alzheimer's variants do indeed react differently to medicines, so that we can treat everyone with appropriate medicines in the future.
https://www.nature.com/articles/s43587-023-00550-7
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fcerebrospinal-fluid_8&filter=22
Different biological variants discovered in Alzheimer's disease
- 853 views
- Added
Latest News
Molecular mechanisms of som…
By newseditor
Posted 01 Jul
A distinct macrophage popul…
By newseditor
Posted 30 Jun
Sex differences in neurolog…
By newseditor
Posted 30 Jun
A neutralizing antibody blo…
By newseditor
Posted 30 Jun
Novel epigenic editor, CHAR…
By newseditor
Posted 30 Jun
Other Top Stories
Growth failure in preterm infants tied to altered gut bacteria
Read more
Targeting gut microbes to treat undernourished children
Read more
Healthy high-fiber diet may reduce preeclampsia risk
Read more
Collaboration between B cells and T cells in celiac disease
Read more
ADHD medication may affect brain development in children
Read more
Protocols
Monitoring norepinephrine r…
By newseditor
Posted 01 Jul
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Publications
Monitoring melanoma patient…
By newseditor
Posted 30 Jun
Loss of GPR75 protects agai…
By newseditor
Posted 30 Jun
Effects of evening smartpho…
By newseditor
Posted 30 Jun
Antibody-activation of conn…
By newseditor
Posted 30 Jun
Mechanism of chaperone coor…
By newseditor
Posted 29 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar